KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nova (NVMI) Inventory (2016 - 2025)

Nova filings provide 17 years of Inventory readings, the most recent being $183.7 million for Q4 2025.

  • On a quarterly basis, Inventory rose 868.59% to $183.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $183.7 million, a 868.59% increase, with the full-year FY2025 number at $183.7 million, up 868.59% from a year prior.
  • Inventory hit $183.7 million in Q4 2025 for Nova, roughly flat from $183.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $183.7 million in Q4 2025 to a low of -$28.9 million in Q3 2023.
  • Median Inventory over the past 5 years was $27.9 million (2021), compared with a mean of $55.5 million.
  • The widest YoY moves for Inventory: up 4667.75% in 2021, down 369796.97% in 2021.
  • Nova's Inventory stood at -$18.5 million in 2021, then skyrocketed by 731.74% to $116.6 million in 2022, then rose by 18.52% to $138.2 million in 2023, then crashed by 117.29% to -$23.9 million in 2024, then skyrocketed by 868.59% to $183.7 million in 2025.
  • The last three reported values for Inventory were $183.7 million (Q4 2025), $183.1 million (Q3 2025), and -$15.4 million (Q2 2025) per Business Quant data.